Donald Southard has left his position as vice president of salesand marketing at Elscint's U.S. subsidiary in Hackensack, NJ,for a position at cardiac monitoring firm Datascope. Southard'sdeparture was amicable, according to Dr. Thomas Spackman,
Donald Southard has left his position as vice president of salesand marketing at Elscint's U.S. subsidiary in Hackensack, NJ,for a position at cardiac monitoring firm Datascope. Southard'sdeparture was amicable, according to Dr. Thomas Spackman, presidentof the subsidiary.
"Don was terrific," Spackman said. "He broughtimagination, direction, enthusiasm, and fun to Elscint."
Southard joined Elscint in 1994 after serving as presidentand CEO of independent service provider Serviscope. He has alsoworked for OEMs Philips and Toshiba. Spackman has taken over Southard'sresponsibilities temporarily, while Elscint undergoes a reviewof its corporate organization that may result in changes to thesubsidiary's executive lineup, Spackman said.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.